Results 1 to 10 of about 21,131,694 (177)

Urolithin A Protects Ovarian Reserve Via Inhibiting PI3K/Akt Signaling and Preventing Chemotherapy-Induced Follicle Apoptosis [PDF]

open access: yesBiology
Urolithin A, which is a natural gut microbial metabolite, exerts multiple beneficial effects upon supplementation, including prolonging lifespan, mitigating diseases, restoring the quality of aged oocytes and alleviating drug toxicity.
Weiyong Wang   +3 more
doaj   +3 more sources

Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer [PDF]

open access: yesFrontiers in Pharmacology
BackgroundThe natural killer (NK) activity of peripheral blood mononuclear cells (PBMCs) is a crucial defense against the onset and spread of cancer.
Vladimir Rogovskii   +10 more
doaj   +3 more sources

Determination of Urolithin A in Health Products by Ultra-High-Performance Liquid Chromatography [PDF]

open access: yesMolecules
This study establishes and validates a novel ultra-high-performance liquid chromatography (UHPLC) method for the determination of urolithin A content in health products, a bioactive compound with potential anti-aging properties.
Yue E, Zhuang Wang, Jiahui Nie
doaj   +3 more sources

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy [PDF]

open access: yesMicrobiome
Background Gut microbiota-derived urolithins may influence multiple myeloma (MM) disease progression and treatment. We analyzed urolithins and their associated microbiota in a retrospective cohort of 45 patients with active MM or premalignant disease ...
Alba Rodríguez-García   +18 more
doaj   +3 more sources

The presence and induction of regioselective dehydroxylases dictate urolithin metabolism by Enterocloster species [PDF]

open access: yesnpj Biofilms and Microbiomes
Urolithins are a class of bioactive metabolites derived from the metabolism of dietary ellagitannins by the human gut microbiota. In the gut, urolithins are dehydroxylated regioselectively based on microbiota composition and activity.
Reilly Pidgeon   +3 more
doaj   +2 more sources

Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges. [PDF]

open access: yesBiomedicines
With the global trend of population aging becoming increasingly pronounced, the incidence of central nervous system (CNS) disorders continues to rise, posing a significant challenge to public health systems worldwide.
Zhang Q, Zhang W, Yuan X, Peng X, Hu G.
europepmc   +2 more sources

The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro [PDF]

open access: yesFrontiers in Pharmacology, 2021
Scope: Ellagitannins are polyphenols found in numerous fruits, nuts and seeds. The elagitannin punicalagin and its bioactive metabolites ellagic acid and urolithins are discussed to comprise a high potential for therapeutically or preventive medical ...
Nina A. Hering   +4 more
doaj   +3 more sources

Functionalized hydrogels of CeO2 and Urolithin A synergistically scavenge ROS and activate mitophagy for cartilage repair [PDF]

open access: yesMaterials Today Bio
In recent years, CeO2 nanoparticles are promising biomaterials due to their excellent biocompatibility and antioxidant properties. This study utilizes a methacrylated gelatin (GelMA) hydrogel platform to construct a dual-functional composite material ...
Chunhui Ma   +5 more
doaj   +2 more sources

Urolithin A Alleviates Doxorubicin-Induced Senescence in Mesenchymal Stem Cells. [PDF]

open access: yesInt J Mol Sci
The accumulation of senescent cells, characterized by a pro-inflammatory secretory phenotype (SASP), metabolic dysfunction, and irreversible cell cycle arrest, is a driving force behind numerous age-related pathologies and directly undermines the ...
Kalinin A   +3 more
europepmc   +2 more sources

Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine. [PDF]

open access: yesNanotheranostics
Cancer remains a leading global health challenge, with high mortality rates persisting despite significant advancements in therapeutic interventions. Major obstacles, including systemic toxicity, therapy resistance, metastasis, and relapses, emphasize ...
Karumuru V   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy